Inovo Inc. reaffirmed that its CHAD Therapeutics devices are still very much alive and kicking.
Inovo, which purchased the oxygen conserving assets of CHAD Therapeutics, as well as the right to market under the name CHAD Therapeutics, issued a statement to clarify that it is in no way affiliated with the company CHAD Therapeutics Inc., which recently announced the suspension of its operations.
Inovo Inc. successfully moved the production of CHAD’s oxygen conserving devices to its facility in Naples, Fla. this summer.
